Surgery/Cosmetic

Favorable Results for DOAC After Peripheral Intervention



<![CDATA[]]>(MedPage Today) — People who took rivaroxaban (Xarelto) after lower-extremity revascularization for peripheral artery disease (PAD) enjoyed fewer subsequent major adverse limb and cardiovascular events, according to the VOYAGER PAD trial.
The…

Source link

Related posts

What to Expect During a Mommy Makeover Consultation

Newsemia

Only 2 Days Left to Can the Griz!

Newsemia

Penile Enhancement at Westlake Plastic Surgery (Yes, Really)

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World